ask="100.00"
ask_size="200"
average_daily_volume="422338"
bid="N/A"
bid_size="N/A"
book_value="11.49"
change="-0.96"
change_from_200_day_moving_average="11.42"
change_from_50_day_moving_average="5.12"
change_from_52_week_high="-6.74"
change_From_52_week_low="38.09"
change_in_percent="-1.12%"
close="84.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.11"
eps_estimate_next_quarter="-1.78"
eps_estimate_next_year="-6.45"
ex_dividend_date="N/A"
float_shares="38578000"
high="86.14"
high_52_weeks="91.35"
last_trade_date="3/17/2017"
last_trade_price="84.61"
last_trade_size="243888"
last_trade_time="4:00pm"
low="84.01"
low_52_weeks="46.52"
market_capitalization="3.53B"
moving_average_200_day="73.19"
moving_average_50_day="79.49"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.71"
open="84.48"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+15.60%"
percent_change_from_50_day_moving_average="+6.44%"
percent_change_from_52_week_high="-7.37%"
percent_change_from_52_week_low="+81.88%"
previous_close="85.57"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.44"
price_per_sales="26844.25"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="11.26"
stock_exchange="NMS"
symbol="RARE"
volume="944044"
weeks_range_52="46.52 - 91.35"
